Patent · US Expired

3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives

US6552036B2 · kind B2 · utility

15Cited by

0References

25Claims

0Family size

Assignee

Ortho-McNeil Pharmaceutical, Inc. · US

Inventors

Robert E. Boyd · Horsham, US
John R. Carson · Norristown, US
Steven J. Coats · McDonough, US
Lou Anne Neilson · Sellersville, US
Philip Pitis · Valley Forge, US
Wu-Nan Wu · Lansdale, US

Key dates

Filing date	Feb 22, 2001
Grant date	Apr 22, 2003
Priority date	—
Expiry date	Feb 22, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is directed to 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives useful as &dgr;-opioid or &mgr;-opioid receptor modulators. Depending on their agonist or antagonist effect, the compounds are useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.